Medical network - on January 6, 2017, some prices may still rise! Because the API began in price.
▍ micro friends fact: API rose by more than 20 times
Price rises in price rise in price! Nearly a period, the background micro friends often received message, request to address the concerns of API price. The message said, a lot of API in rise, some even rose by more than 20 times, drive the preparation are also beginning to rapidly rising prices.
In fact, as early as the beginning of 2016's "two sessions", through market research, the National People's Congress, sichuan good doctor pharmaceutical group co., LTD., chairman of the board of directors can GengFu, medicine apis monopoly phenomenon is more serious in recent years, he thinks this is also one of the main factors that cause drug prices.
According to Beijing business today reported earlier, at home, part of the API or even up about 31 times in less than 2 years.
In this context, the choke preparation medicine, or with price, inherit from channel, terminal, accusing carries some risk that the brand credibility; Or simply cut production accident, according to previous reports, all of the reasons behind "digoxin tablets price event", is the fault of the price of API.
But worry is, API price does not seem to be cool, but from the source to the end product sales market price premium and are inevitable.
▍ substandard housing production! Enterprise facing environmental ShengSiGuan API
API price increases, the fundamental reason for the increase of the environmental cost is the cost especially.
According to a report in the China environment news, China's first of local pollutants emission standards for chemical pharmaceuticals, the chemical synthetic pharmaceutical air pollutants emission standards recently in zhejiang.
"" standard" from the main pollutant of atmosphere pollution VOCs control, this paper will improve the air quality in zhejiang pharmaceutical industry agglomeration area environment, intrusive or pharmaceutical companies stench and VOCs pollutant emissions have a positive impact." Zhejiang province department of environmental protection science and technology with the cooperation of bureaucracy that "standard" is the equivalent of a technical regulations, and atmospheric pollutants for the pharmaceutical enterprises designated an insurmountable "bottom line" of environmental protection.
According to the "standard" requirement, new project has been on October 1, 2016, the existing enterprise will be executed on October 1, 2018. Then, enterprises will face to make their production and production control, until the enterprise standards.
And as one of China's important production base of active pharmaceutical ingredients, zhejiang API pharmaceutical industry almost half the proportion in the whole province.
Public data shows that chemical pharmaceuticals sales income is 48.1 billion yuan in zhejiang province in 2014, second only to the province of shandong and jiangsu.
And under the global active pharmaceutical ingredients in the production of large transfer trend, zhejiang API gain take-off, rapid development, in short time and entrenched in places such as shandong, northeast old API "bosses" rival, also once take half of domestic active pharmaceutical ingredients.
▍ API is generally the price
Since this year, active pharmaceutical ingredients from the environmental pressure of industry will continue to grow. High environmental costs will lead to a contraction of supply for pharmaceutical industry reform and long-term supply side depressed prices also prompted some small businesses, which can lead to tight supply and rising prices. Industry supply contract, the high concentration of varieties have stronger bargaining power.
In fact, a lot of API price. Since 2016, according to health network, various fermentation enterprise due to the environmental protection is more and more strict, the indicators of environmental protection investment continues to increase, directly lead to the rising cost.
And influenced by erythromycin thiocyanate recent price increases, the downstream manufacturers to raise prices of erythromycin, azithromycin latest price 690 yuan/kg; Clarithromycin quote 1150 yuan/kg; ROM erythromycin quote 550 yuan/kg. At the early stage of the erythromycin thiocyanate lowest price of 270 ~ 270 yuan/kg; The central environmental protection the second batch of inspection has been stationed in hubei province events, make the domestic manufacturer to latest price of 310 ~ 315 yuan/kg.
Market analysis view, under the high environmental cost, has the possibility of production of medium and small capacity and production is very small, active pharmaceutical ingredients supply tense situation will continue for quite a long time, prices are expected to continue.
▍ 2017, prices rise, also not necessarily available?
Make sales circle of friends were flow the so "don't ask will not reduce the price, should ask and have no goods!" Even if this sentence has certain marketing, but also reflects the current situation from the side. Environmental problems restrict the chemical pharmaceuticals, cause from preparation medicine companies to channels, terminals, the chain reaction of patients.
At the same time, the environmental pressure also will continue.
As health care expert consultation committee under the state council, the director of health care research center, renmin university of China Wang Hufeng puts it, "if give priority to health status, you must ask governance haze priority, this is the construction of healthy state determination, governance haze is" healthy China "the most direct and urgent problems facing the".
Contact is widely distributed in from the north to the south China national large-scale fog haze, outcry from the public for air pollution control, and scheduling for the shijiazhuang atmospheric pollution prevention before many veteran drug firms, were ordered to stop production under pressure from the management of environmental protection and cost of the power, may be than enterprise thought, be faster and more violent.
In 2017, the drug prices seemed inevitable, you ready? |
